Clinical trial
Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic…
NCT00335569 · IBSA Institut Biochimique SA, Industry · Completed
Key facts
| NCT number | NCT00335569 |
|---|---|
| Title | Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation |
| Official title | A Prospective, Randomized, Controlled Clinical Study on the Assessment of Tolerance and Clinical Equivalence of hCG- IBSA (IBSA) Versus Ovitrelle (Serono), Both Administered Sub-cutaneously in Women Undergoing in Vitro Fertilization (IVF). |
| Lead sponsor | IBSA Institut Biochimique SA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug |
| Interventions | hCG-IBSA |
| Enrollment | 144 |
| Start date | Aug 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Jun 12, 2006 |
| Last update posted | Jun 1, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: